Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis

JACC: Cardiovascular Interventions

Volumn 8, Issue 12, 2015, Pages 1586-1594

  Kawamoto, Hiroyoshi ^a,b   Ruparelia, Neil ^a,b,c   Latib, Azeem ^a,b   Miyazaki, Tadashi ^a,b   Sato, Katsumasa ^a,b   Mangieri, Antonio ^a   Contri, Rachele ^a   Stella, Stefano ^a   Figini, Filippo ^a,b   Chieffo, Alaide ^a   Carlino, Mauro ^a   Montorfano, Matteo ^a   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

drug coated balloon; drug eluting stent; in stent restenosis

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS; BIOMATERIAL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; DRUG COATED BALLOON; DRUG ELUTING CORONARY STENT; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; RECURRENT DISEASE; REVASCULARIZATION; THROMBOSIS; ZOTAROLIMUS ELUTING CORONARY STENT; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DEVICES; DRUG ELUTING STENT; HEART CATHETER; ITALY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; RISK FACTOR; TIME FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CATHETERS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84946486868     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.04.032     Document Type: Article

References (29)

1. G.W. Stone, S.G. Ellis, L. Cannon, and et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 2005 1215 1223
2. J. Mehilli, R.A. Byrne, K. Tiroch, and et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
3. M. Abe, T. Kimura, T. Morimoto, and et al. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry Circulation 122 2010 42 51
4. Y.H. Kim, B.K. Lee, D.W. Park, and et al. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis Am J Cardiol 98 2006 1451 1454
5. H. Kitahara, Y. Kobayashi, H. Takebayashi, and et al. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals Circ J 73 2009 867 871
6. Y.G. Ko, J.S. Kim, B.K. Kim, and et al. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]) Am J Cardiol 109 2012 607 613
7. F. Alfonso, M.J. Perez-Vizcayno, A. Cardenas, and et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent) J Am Coll Cardiol 63 2014 1378 1386
8. A. Kastrati, J. Mehilli, N. von Beckerath, and et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
9. F. Tagliareni, A. La Manna, F. Saia, A. Marzocchi, and C. Tamburino Long-term clinical follow-up of drug-eluting stent restenosis treatment: retrospective analysis from two high volume catheterisation laboratories EuroIntervention 5 2010 703 708
10. F. Alfonso, J. Garcia, M.J. Perez-Vizcayno, and et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries J Am Coll Cardiol 54 2009 1036 1038
11. S. Kubo, K. Kadota, S. Otsuru, and et al. Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions EuroIntervention 9 2013 788 796
12. S. Habara, K. Mitsudo, K. Kadota, and et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 149 154
13. H. Rittger, J. Brachmann, A.M. Sinha, and et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
14. B. Scheller, C. Hehrlein, W. Bocksch, and et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
15. F.X. Kleber, H. Rittger, K. Bonaventura, and et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group Clin Res Cardiol 102 2013 785 797
16. K. Thygesen, J.S. Alpert, and H.D. White Joint ESC/ACCF/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
17. K. Thygesen, J.S. Alpert, A.S. Jaffe, and et al. Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
18. D.E. Cutlip, S. Windecker, R. Mehran, and et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
19. A. Kastrati, A. Schomig, S. Elezi, H. Schuhlen, M. Wilhelm, and J. Dirschinger Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions Circulation 97 1998 2396 2401
20. A. Latib, L. Ferri, A. Ielasi, and et al. Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts Circ Cardiovasc Interv 3 2010 249 256
21. F. Alfonso, M.J. Perez-Vizcayno, R. Hernandez, and et al. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study J Am Coll Cardiol 52 2008 1621 1627
22. M. Unverdorben, C. Vallbracht, B. Cremers, and et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
23. R.A. Byrne, F.-J. Neumann, J. Mehilli, and et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
24. S.J. Kang, G.S. Mintz, D.W. Park, and et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis Circ Cardiovasc Interv 4 2011 9 14
25. M. Habara, M. Terashima, K. Nasu, and et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study Eur Heart J Cardiovasc Imaging 14 2013 276 284
26. A. Latib, M. Mussardo, A. Ielasi, and et al. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 155 164
27. J. Cosgrave, G. Melzi, G.G. Biondi-Zoccai, and et al. Drug-eluting stent restenosis the pattern predicts the outcome J Am Coll Cardiol 47 2006 2399 2404
28. A. Ielasi, A. Latib, T. Naganuma, and et al. Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis Int J Cardiol 173 2014 513 514
29. F. Alfonso, M.J. Perez-Vizcayno, A. Cardenas, and et al. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis) EuroIntervention 11 2015 336 342